Evaluation of patients treated with HMG-CoA reductase inhibitors to reach cholesterol target values

Study identifier:NIS-CBA-CRE-2011/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Non-interventional study to assess reaching of cholesterol target values in patients treated with HMG-CoA reductase inhibitors in Bosnia and Herzegovina

Medical condition

hypercholesterolaemia

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

800

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 Apr 2012
Primary Completion Date: 01 Jan 2013
Study Completion Date: 01 Jan 2013

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Sept 2014 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria